ExodusPoint Capital Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,935
| Closed | -$1.05M | – | 2209 |
|
|
2023
Q1 | $1.05M | Sell |
5,935
-4,378
| -42% | -$774K | 0.01% | 1033 |
|
|
2022
Q4 | $3.99M | Buy |
10,313
+6,687
| +184% | +$2.59M | 0.06% | 396 |
|
|
2022
Q3 | $1.22M | Buy |
3,626
+105
| +3% | +$35.4K | 0.02% | 995 |
|
|
2022
Q2 | $1.16M | Buy |
3,521
+2,100
| +148% | +$690K | 0.01% | 967 |
|
|
2022
Q1 | $622K | Buy |
1,421
+638
| +81% | +$279K | 0.01% | 1348 |
|
|
2021
Q4 | $343K | Buy |
+783
| New | +$343K | ﹤0.01% | 1570 |
|
|
2021
Q3 | – | Sell |
-497
| Closed | -$255K | – | 2667 |
|
|
2021
Q2 | $255K | Sell |
497
-946
| -66% | -$485K | ﹤0.01% | 1761 |
|
|
2021
Q1 | $1.13M | Buy |
+1,443
| New | +$1.13M | 0.02% | 805 |
|
|
2020
Q4 | – | Sell |
-608
| Closed | -$278K | – | 2372 |
|
|
2020
Q3 | $278K | Buy |
608
+150
| +33% | +$68.6K | 0.01% | 1263 |
|
|
2020
Q2 | $282K | Buy |
+458
| New | +$282K | 0.01% | 1324 |
|
|
2020
Q1 | – | Sell |
-577
| Closed | -$334K | – | 1669 |
|
|
2019
Q4 | $334K | Buy |
+577
| New | +$334K | 0.01% | 1038 |
|